GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Charles River Laboratories International Inc (STU:RV6) » Definitions » Ending Cash Position

Charles River Laboratories International (STU:RV6) Ending Cash Position : €168 Mil (As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Charles River Laboratories International Ending Cash Position?

Charles River Laboratories International's Ending Cash Position for the quarter that ended in Jun. 2024 was €168 Mil.

Charles River Laboratories International's quarterly Ending Cash Position increased from Dec. 2023 (€261 Mil) to Mar. 2024 (€311 Mil) but then declined from Mar. 2024 (€311 Mil) to Jun. 2024 (€168 Mil).

Charles River Laboratories International's annual Ending Cash Position increased from Dec. 2021 (€218 Mil) to Dec. 2022 (€228 Mil) and increased from Dec. 2022 (€228 Mil) to Dec. 2023 (€261 Mil).


Charles River Laboratories International Ending Cash Position Historical Data

The historical data trend for Charles River Laboratories International's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charles River Laboratories International Ending Cash Position Chart

Charles River Laboratories International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 216.04 191.62 217.99 227.71 260.87

Charles River Laboratories International Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.70 155.18 260.87 311.45 168.15

Charles River Laboratories International Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Charles River Laboratories International's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=221.194+39.674
=261

Charles River Laboratories International's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=314.5+-146.347
=168


Charles River Laboratories International Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Charles River Laboratories International's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Charles River Laboratories International Business Description

Traded in Other Exchanges
Address
251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Charles River Laboratories International Headlines

No Headlines